Related Experiment Videos
Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging
M Schechter1, R Zajdenverg, L L Machado
1AIDS Program, Hospital Universitario Clementino Fraga Filho, Federal University of Rio de Janeiro, Brazil.
Insights
Predicting low CD4 cell counts is crucial for HIV management. This study developed models using the WHO staging system and basic lab tests, achieving over 90% sensitivity and 83% specificity for CD4 counts below 200 cells/mm3.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- CD4 cell counts are vital surrogate markers for HIV disease progression and guide treatment initiation.
- Current CD4 count measurement methods are often too expensive for widespread use in developing countries.
Purpose of the Study:
- To develop a predictive model for CD4 counts below 200 cells/mm3 using the World Health Organization (WHO) HIV staging system and accessible laboratory parameters.
- To provide a cost-effective alternative for identifying individuals needing intervention in resource-limited settings.
Main Methods:
- A prospective cohort study included 106 treatment-naive HIV-infected patients.
- Two predictive models were developed using the WHO staging system, hematocrit, and total lymphocyte counts.
- Lymphocyte phenotyping was performed via flow cytometry.
Main Results:
- The developed models demonstrated high predictive accuracy.
- Sensitivity exceeded 90% and specificity surpassed 83% for predicting CD4 counts < 200 cells/mm3.
- Simple clinical and laboratory parameters effectively predicted low CD4 counts.
Conclusions:
- Combined use of WHO staging and basic laboratory tests can reliably predict low CD4 counts in HIV patients.
- This approach offers a potentially universal and cost-effective strategy for HIV management in resource-limited settings.
- Further validation in diverse populations is recommended to confirm applicability and guide intervention strategies.
Abstract:
CD4 cell counts are one of the best available surrogate markers for disease progression; they are widely used laboratory parameters in clinical trials and commonly used indicators for the introduction of primary prophylaxis and antiretroviral therapy. However, measurement is too expensive to be done in most developing countries. The objective of this study was to derive a model for prediction of CD4 counts < 200 cells/mm3 based on the proposed World Health Organization (WHO) staging system for HIV infection and widely available laboratory parameters. One hundred and six consecutive patients enrolled in a prospective cohort study who were not taking anti-HIV drugs or prophylaxis for opportunistic infections were included. Blood tests were performed within 72 h of the outpatient visit. Lymphocyte phenotyping was done by flow cytometry. Two models based on the WHO staging system, hematocrit and total lymphocyte counts, were developed. The two models had sensitivity > 90% and specificity > 83%. These results indicate that the combined use of simple clinical and laboratory parameters can predict CD4 counts < 200 cells/mm3 with high sensitivity and specificity. Similar studies should be conducted in other countries. Should our findings be confirmed, intervention strategies based on this model of potential universal applicability should be devised and validated.